Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Long-term effects of immunotherapy with a brain penetrating Aβ antibody in a mouse model of Alzheimer’s disease
Tobias Gustavsson, Nicole G. Metzendorf, Elin Wik, et al.
Alzheimer s Research & Therapy (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 11

Showing 11 citing articles:

Bispecific antibody drug conjugates: Making 1+1>2
Yilin Gu, Zhijia Wang, Yuxi Wang
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 5, pp. 1965-1986
Open Access | Times Cited: 32
Amyloid-β-targeting immunotherapies for Alzheimer's disease
Yi Jin, Qiaofei Du, Mingjie Song, et al.
Journal of Controlled Release (2024) Vol. 375, pp. 346-365
Closed Access | Times Cited: 8
Current Anti-Amyloid-β Therapy for Alzheimer’s Disease Treatment: From Clinical Research to Nanomedicine
Zixuan Zhao, Yun Liu, Shirong Ruan, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 7825-7845
Open Access | Times Cited: 18
Cryo-EM of Aβ fibrils from mouse models find tg-APPArcSwe fibrils resemble those found in patients with sporadic Alzheimer’s disease
Mara Zielinski, Fernanda S. Peralta Reyes, Lothar Gremer, et al.
Nature Neuroscience (2023) Vol. 26, Iss. 12, pp. 2073-2080
Open Access | Times Cited: 16
Reducing neonatal Fc receptor binding enhances clearance and brain-to-blood ratio of TfR-delivered bispecific amyloid-β antibody
Eva Schlein, Karl Andersson, Tiffany D. Dallas, et al.
mAbs (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 6
Targeting terminal pathway reduces brain complement activation, amyloid load and synapse loss, and improves cognition in a mouse model of dementia
Wioleta M. Zelek, Ryan J. Bevan, B. Paul Morgan
Brain Behavior and Immunity (2024) Vol. 118, pp. 355-363
Open Access | Times Cited: 4
Advancements and challenges in mouse models of Alzheimer’s disease
Zhengjiang Qian, Yanjiao Li, Keqiang Ye
Trends in Molecular Medicine (2024)
Closed Access | Times Cited: 3
Altered amyloid-β structure markedly reduces gliosis in the brain of mice harboring the Uppsala APP deletion
María Pagnon de la Vega, Stina Syvänen, Vilmantas Giedraitis, et al.
Acta Neuropathologica Communications (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 1
Antibody engagement with amyloid‐beta does not inhibit [11C]PiB binding for PET imaging
Mengfei Xiong, Amelia D. Dahlén, Sahar Roshanbin, et al.
Journal of Neurochemistry (2024)
Open Access
A brain-penetrant bispecific antibody lowers oligomeric alpha-synuclein and activates microglia in a mouse model of alpha-synuclein pathology
Dag Sehlin, Sahar Roshanbin, Olof Zachrisson, et al.
Neurotherapeutics (2024), pp. e00510-e00510
Open Access
Early astrocytic dysfunction is associated to mistuned synapses as well as anxiety and depressive-like behavior in the AppNL-F mouse model of Alzheimers disease
Benjamin Portal, Moa Södergren, Teo Parés i Borrell, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top